Metropolitan Digital

Men's Weekly


.

Promising new drug for treatment-resistant depression – esketamine

  • Written by Lee Hoffer, Associate Professor of Anthropology; Professor of Psychiatry, Case Western Reserve University
Promising new drug for treatment-resistant depression – esketamineOne in 3 people with severe depression do not respond to treatment.TZIDO SUN/Shutterstock.com

Treatment-resistant depression affects 1 in 3 of the estimated 16.2 million adults in the U.S. who have suffered at least one major depressive episode. For them, two or more therapies have failed and the risk of suicide is much greater. It’s a grim...

Read more: Promising new drug for treatment-resistant depression – esketamine

More Articles ...

  1. The revolving door between media and government spins again with CNN's hiring of Sarah Isgur Flores
  2. Zebra's stripes are a no fly zone for flies
  3. Theodore McCarrick will continue to be a Catholic priest
  4. US sanctions on Venezuelan oil could cut the output of refineries at home
  5. How to keep conservation policies from backfiring in a globally connected world
  6. Paid family leave is an investment in public health, not a handout
  7. One-party rule in 49 state legislatures reflects flaws in democratic process
  8. Iraq's brutal crackdown on suspected Islamic State supporters could trigger civil war
  9. Hundreds of genes linked to blindness could lead to new therapies
  10. Why US cities are becoming more dangerous for cyclists and pedestrians
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more